Liposome encapsulated albumin-paclitaxel nanoparticle for enhanced antitumor efficacy. (Q53020846)

10 May 2018

title

Liposome encapsulated albumin-paclitaxel nanoparticle for enhanced antitumor efficacy. (English)

1 reference

10 May 2018

0 references

Hima Bindu Ruttala

1

1 reference

10 May 2018

Young Tag Ko

series ordinal

2

1 reference

10 May 2018

publication date

12 September 2014

1 reference

10 May 2018

published in

Pharmaceutical Research

1 reference

10 May 2018

volume

32

1 reference

10 May 2018

issue

3

1 reference

10 May 2018

page(s)

1002-1016

1 reference

10 May 2018

Taxol: a novel investigational antimicrotubule agent

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

Paclitaxel and its formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

Discriminated effects of thiolated chitosan-coated pMMA paclitaxel-loaded nanoparticles on different normal and cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane®.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

Formulation optimization of paclitaxel carried by PEGylated emulsions based on artificial neural network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

A new hydrotropic block copolymer micelle system for aqueous solubilization of paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

A novel polymer-paclitaxel conjugate based on amphiphilic triblock copolymer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

Albumin-bound paclitaxel: a next-generation taxane

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

Comparative preclinical and clinical pharmacokinetics of a cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in Cremophor (Taxol).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

Modulation of drug resistance in ovarian adenocarcinoma by enhancing intracellular ceramide using tamoxifen-loaded biodegradable polymeric nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

Liposomal paclitaxel formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

Development of liposomal anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

Cationic liposomes loaded with proapoptotic peptide D-(KLAKLAK)(2) and Bcl-2 antisense oligodeoxynucleotide G3139 for enhanced anticancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

Storage stability of optimal liposome-polyethylenimine complexes (lipopolyplexes) for DNA or siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

Self-assembling micelle-like nanoparticles based on phospholipid-polyethyleneimine conjugates for systemic gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

Design and development of paclitaxel-loaded bovine serum albumin nanoparticles for brain targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

High affinity binding of paclitaxel to human serum albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

Paclitaxel-HSA interaction. Binding sites on HSA molecule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

Human serum albumin: spectroscopic studies of the paclitaxel binding and proximity relationships with cisplatin and adriamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

Paclitaxel loaded carrier based biodegradable polymeric implants: Preparation and in vitro characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

A docetaxel-carboxymethylcellulose nanoparticle outperforms the approved taxane nanoformulation, Abraxane, in mouse tumor models with significant control of metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

Formulation and evaluation of paclitaxel-loaded polymeric nanoparticles composed of polyethylene glycol and polylactic acid block copolymer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

Chitosan-based polyelectrolyte complexes as potential nanoparticulate carriers: physicochemical and biological characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

A nontoxic disulfide bond reducing method for lipophilic drug-loaded albumin nanoparticle preparation: formation dynamics, influencing factors and formation mechanisms investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

Paclitaxel-loaded polymeric micelles based on poly(ɛ-caprolactone)-poly(ethylene glycol)-poly(ɛ-caprolactone) triblock copolymers: in vitro and in vivo evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

Novel dual drug-loaded block ionomer complex micelles for enhancing the efficacy of chemotherapy treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

Paclitaxel-loaded poly(N-vinylpyrrolidone)-b-poly(epsilon-caprolactone) nanoparticles: preparation and antitumor activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

Chitosan oligosaccharide-arachidic acid-based nanoparticles for anti-cancer drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

Enhanced antitumor efficacy by paclitaxel-loaded pluronic P123/F127 mixed micelles against non-small cell lung cancer based on passive tumor targeting and modulation of drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

Liposome encapsulated polyethylenimine/ODN polyplexes for brain targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

pH sensitive polyelectrolyte complex micelles for highly effective combination chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1512-2

Hypersensitivity reactions from taxol

21 January 2018

1 reference

12 December 2020

A phase I clinical and pharmacokinetic study of paclitaxel liposome infused in non-small cell lung cancer patients with malignant pleural effusions

1 reference

12 December 2020

Effects of prolonged versus short-term exposure paclitaxel (Taxol) on human tumor colony-forming units

1 reference

12 December 2020

Stable paclitaxel formulations in oily contrast medium

1 reference

12 December 2020

Supramolecular core-shell nanosilica@liposome nanocapsules for drug delivery

1 reference

12 December 2020

The clinical pharmacology of paclitaxel (Taxol).

1 reference

12 December 2020

10.1007/S11095-014-1512-2

Identifiers

DOI

1 reference

10 May 2018

PubMed ID

25213777

1 reference

10 May 2018